RT Book, Section
A1 Golbe, Lawrence I.
A2 Watts, Ray L.
A2 Standaert, David G.
A2 Obeso, Jose A.
SR Print(0)
ID 55796283
T1 Chapter 21. Progressive Supranuclear Palsy
T2 Movement Disorders, 3e
YR 2012
FD 2012
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-161312-5
LK accessphysiotherapy.mhmedical.com/content.aspx?aid=55796283
RD 2023/09/27
AB The  first  clinicopathologic  descriptions  of  progressive  supranuclear  palsy  (PSP)  to  draw  widespread  attention  were  published  in  1963  and  1964.1–3  The  full-blown,  typical  case  is  at  once  unusually  complex  in  its  combination  of  motor  and  behavioral  features  and  so  distinctive  that  the  diagnosis  is  unmistakable  at  a  glance.  Lack  of  objective  diagnostic  markers  and  poor  response  to  treatment  make  PSP  a  challenge  for  the  clinician  and  a  trial  for  the  patient  and  family.  But  recent  progress  in  understanding  its  genetic,  molecular,  and  cellular  pathology  offer  hope  that  PSP  will  become  more  easily  diagnosed  and  treated  in  the  near  future.